Hand sanitizer and surface cleaner company Byotrol had a strong 2020 and are confident about 2021 Watch Now

Less Ads, More Data, More Tools Register for FREE

Italy could have AstraZeneca COVID-19 shots by end November, IRBM biotech says

Wed, 16th Sep 2020 19:13

ROME, Sept 16 (Reuters) - Italy could have its first shots
of British drugmaker AstraZeneca's potential COVID-19
vaccine by the end of November, the managing director of IRBM
told Reuters.

Biotech firm IRBM, whose lab is based south of Rome, is
cooperating with AstraZeneca in developing a vaccine for the
disease which has caused more than 35,600 deaths in Italy.

"It is possible to have the first shots in Italy by the end
of November, provided the trial continues as planned and the
vaccine is validated," Matteo Liguori said on Wednesday.

Italy's Health Minister had already said the vaccine could
be available by the end of 2020.
(Reporting by Emilio Parodi; Writing by Angelo Amante; Editing
by Alexander Smith)

Related Shares

More News

Covid-19 deaths reach 1m, WHO claims virus still suppressible

(Sharecast News) - The World Health Organization (WHO) said on Tuesday that the number of global deaths from Covid-19 had reached 1m but that the virus was still suppressible.

Today 11:23

UK BROKER RATINGS SUMMARY: Berenberg Says Buy AstraZeneca And Glaxo

UK BROKER RATINGS SUMMARY: Berenberg Says Buy AstraZeneca And Glaxo

Today 09:37

Inovio shares crash after FDA places partial hold on Covid-19 trial

(Sharecast News) - Inovio's phase 2/3 trial of its Covid-19 vaccine candidate was put on partial hold by the US Food and Drug Administration, sending the shares crashing.

28 Sep 20 13:30

AstraZeneca Appoints Stanford University Professor Ashley To Board

AstraZeneca Appoints Stanford University Professor Ashley To Board

25 Sep 20 08:30

Login to your account

Don't have an account? Click here to register.